Results 31 to 40 of about 1,621 (163)

Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

open access: yesPediatric Pulmonology, Volume 55, Issue 7, Page 1725-1735, July 2020., 2020
Abstract Rationale Bronchiolitis obliterans syndrome (BOS) is a severe, chronic inflammation of the airways leading to an obstruction of the bronchioles. So far, there are only a few studies looking at the long‐term development of pulmonary impairment in children with BOS.
Sophie Walther   +10 more
wiley   +1 more source

Situation of anti-fungal resistance of species of the genus Candida in Peru

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2018
We are currently witnessing a constant and ongoing change of the epidemiological pictures of yeast resistance to antifungal agents, related to the type of host, etiology of the disease, the microorganism involved, and its mechanisms of resistance.
Susana Zurita Macalupú
doaj   +1 more source

FUSARIOSE EM PACIENTE COM LINFOMA LINFOBLÁSTICO T - RELATO DO CASO

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Relatar um caso de infecção fúngica invasiva por fusarium em paciente com Linfoma Linfoblástico T. Relato de caso: P. F. M. C., 38 anos, sexo feminino, deu entrada em nosso serviço em fevereiro de 2021 com diagnóstico de Linfoma Linfoblástico T
FC Domingos   +8 more
doaj   +1 more source

Cuerpo extraño vegetal intrabronquial con colonización por Aspergillus [PDF]

open access: yesRevista SOCAMPAR, 2019
La aspiración de cuerpo extraño en la vía aérea es poco frecuente en adultos. Es poco probable que se relate el episodio de atragantamiento espontáneamente como antecedente claro y suele pasar inadvertido.
Arroyo-Cózar M,   +2 more
doaj  

In silico, in vitro und in vivo Charakterisierung der Hemmung ausgewählter Fremdstoff-metabolisierender Enzyme des Menschen durch Voriconazol [PDF]

open access: yes, 2016
Zur Präzisierung des inhibitorischen Potentials des etablierten Antimykotikums Voriconazol auf ausgewählte, den Midazolam-Metabolismus betreffende Enzyme wurden Inhibitionsstudien in vitro und in vivo durchgeführt, um Interaktionen unter Beteiligung von ...
Junge, Lisa
core   +1 more source

Atividade in vitro, individual ou em combinação, de voriconazol, itraconazol e terbinafina contra isolados brasileiros de Pythium insidiosum [PDF]

open access: yes, 2018
Pythium insidiosum,  classificado no Reino Stramenopila e Classe Oomycetes, é o agente etiológico da pitiose, uma doença diagnosticada principalmente em eqüinos, caninos e humanos.
Argenta, Juliana Siqueira
core   +2 more sources

PS1214 INFECTIOUS COMPLICATIONS FOLLOWING ARI‐0001 CELL (A3B1:CD8:4–1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES

open access: yesHemaSphere, Volume 3, Issue S1, Page 553-554, June 2019., 2019
Background: Several chimeric antigen receptor products targeting CD19 are either approved or in development for the treatment of acute lymphoblastic leukemia (ALL) and non‐Hodgkin's lymphoma (NHL). Nevertheless, information on infections and immune impairment caused by this procedure (lymphodepletion chemotherapy, neutropenia, B‐cell aplasia and ...
V. Ortiz‐Maldonado   +21 more
wiley   +1 more source

Validación de un método para determinar la concentración sérica de voriconazol por HPLC/UV

open access: yes, 2022
RESUMEN Antecedentes: El incremento de infecciones fúngicas invasivas ha incrementado el uso de voriconazol como profilaxis y tratamiento, siendo necesario monitorizar sus concentraciones séricas.
Sánchez-de Castro,M   +7 more
core   +1 more source

EHA2021 Virtual Congress Abstract Book

open access: yes, 2021
HemaSphere, Volume 5, Issue S2, June 2021.
wiley   +1 more source

PS1215 SAFETY AND TOLERABILITY OF ALLOGENEIC, OFF‐THE SHELF PLACENTAL NATURAL KILLER CELLS (PNK 007) IN PHASE 1 MULTIPLE MYELOMA AND ACUTE MYELOID LEUKEMIA STUDIES (NCT02955550 AND NCT02781467)

open access: yesHemaSphere, Volume 3, Issue S1, Page 554, June 2019., 2019
Background: PNK‐007 is an allogeneic, off‐the‐shelf cell therapy enriched for CD56+/CD3‐ NK cells expanded from placental CD34+ cells. PNK‐007 exhibits cytotoxicity against various cancer cell types. Aims: Characterize the safety and tolerability of PNK‐007 single‐infusion in subjects (subj) with relapsed/refractory (r/r) AML (completed) and with r/r ...
S. Koppisetti   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy